National Health Investors Inc (NHI) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
National Health Investors Inc stock (NHI) is currently trading at $83.12. National Health Investors Inc PE ratio is 27.34. National Health Investors Inc PS ratio (Price-to-Sales) is 10.55. Analyst consensus price target for NHI is $89.25. WallStSmart rates NHI as Underperform.
- NHI PE ratio analysis and historical PE chart
- NHI PS ratio (Price-to-Sales) history and trend
- NHI intrinsic value — DCF, Graham Number, EPV models
- NHI stock price prediction 2025 2026 2027 2028 2029 2030
- NHI fair value vs current price
- NHI insider transactions and insider buying
- Is NHI undervalued or overvalued?
- National Health Investors Inc financial analysis — revenue, earnings, cash flow
- NHI Piotroski F-Score and Altman Z-Score
- NHI analyst price target and Smart Rating
National Health Investors Inc
📊 No data available
Try selecting a different time range
NHI Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · National Health Investors Inc (NHI)
NHI trades 330% above its Graham fair value of $20.54, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
National Health Investors Inc (NHI) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in operating margin, profit margin, institutional own.. Concerns around peg ratio and return on equity. Mixed signals suggest waiting for clearer direction before acting.
National Health Investors Inc (NHI) Key Strengths (4)
Keeps $63 of every $100 in revenue after operating costs
Keeps $38 of every $100 in revenue as net profit
73.38% of shares held by major funds and institutions
Mid-cap company balancing growth potential with stability
National Health Investors Inc (NHI) Areas to Watch (6)
Revenue declining -11.70%, a shrinking business
Earnings declining -14.10%, profits shrinking
Very expensive relative to growth, significant premium
Very expensive at 10.6x annual revenue
Low profitability relative to shareholder equity
Fairly priced relative to book value
Supporting Valuation Data
National Health Investors Inc (NHI) Detailed Analysis Report
Overall Assessment
This company scores 48/100 in our Smart Analysis, earning a D+ grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.3/10) while 6 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Operating Margin, Profit Margin, Institutional Own.. Profitability is solid with Operating Margin at 62.50%, Profit Margin at 37.50%.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, PEG Ratio. Some valuation metrics including PEG Ratio (4.76), Price/Sales (10.55), Price/Book (2.61) suggest expensive pricing. Growth concerns include Revenue Growth at -11.70%, EPS Growth at -14.10%, which may limit upside. Profitability pressure is visible in Return on Equity at 9.63%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 9.63% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -11.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Revenue Growth and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
NHI Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
NHI's Price-to-Sales ratio of 10.55x trades 47% below its historical average of 19.9x (14th percentile). The current valuation is 69% below its historical high of 34.34x set in Oct 2010, and 45% above its historical low of 7.28x in Apr 2006.
WallStSmart Analysis Synopsis
Data-driven financial summary for National Health Investors Inc (NHI) · REAL ESTATE › REIT - HEALTHCARE FACILITIES
The Big Picture
National Health Investors Inc faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 379M with 12% decline year-over-year. Profit margins are strong at 37.5%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 963.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Profit margin of 37.5% and operating margin of 62.5% demonstrate strong pricing power and operational efficiency.
Revenue contracted 12% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Dividend sustainability with a current yield of 4.4%. Watch payout ratio and free cash flow coverage.
Debt management: total debt of 1.1B is significantly higher than cash (82M). Monitor refinancing risk.
Sector dynamics: monitor REIT - HEALTHCARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact National Health Investors Inc.
Bottom Line
National Health Investors Inc faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About National Health Investors Inc(NHI)
NYSE
REAL ESTATE
REIT - HEALTHCARE FACILITIES
USA
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in the sale and leaseback, joint ventures, mortgages, and interim financing of discretionary and medical-based home and investment investments. in needs.